PharmaCyte Biotech Inc (PMCB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.70
• Market Cap: $7.31M
• EPS: $-1.11
• 52-Week High: $1.84
• 52-Week Low: $0.63

About PharmaCyte Biotech Inc

PharmaCyte Biotech Inc. (PMCB) is a clinical-stage biotechnology company headquartered in Laguna Hills, California, focused on developing cutting-edge cell therapies for cancer and diabetes. Utilizing its proprietary technology platform, the company aims to create transformative treatments that enhance patient outcomes and overall quality of life. With a strategic emphasis on advancing its clinical programs, PharmaCyte Biotech is well-positioned to make significant contributions to the rapidl...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for PharmaCyte Biotech Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PMCB pay dividends?

PharmaCyte Biotech Inc (PMCB) does not currently pay a regular dividend.

What is PMCB's market cap?

PharmaCyte Biotech Inc (PMCB) has a market capitalization of $7.31M with a current stock price of $0.70.